BoxX-NoAF Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 960 participants.
Also called NCT06989775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 960 participants
- Sponsor
- Registry
-
NCT06989775
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06989775. Randomized; triple masking; primary purpose prevention. Start 2025-10-24 (actual); primary completion 2027-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BoxX-NoAF Clinical Trial
- Condition
- Post Operative Atrial Fibrillation
- Condition
- Atrial Fibrillation, Postoperative
- Intervention (Device)
- Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System
- Lead sponsor
- AtriCure, Inc.
Record details
- Record id
cardio:ct-nct06989775- Content hash
f0f20a55034f74783cca4deab65f60b21ee1bc161010a6b552c8c713da8662f6